Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis to investigate bribery claims at Alcon unit in China
Motley Fool
Tuesday, September 17, 2013 - 9:31am
tags:
Novartis, China, Alcon
Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
Motley Fool
Tuesday, September 17, 2013 - 9:29am
tags:
COPD, GSK, Theravance, Anoro Ellipta, Breo Ellipta
Glaxo's Melanoma Drugs Gets FDA Priority Review
PharmaLive
Monday, September 16, 2013 - 5:49pm
tags:
melanoma, GSK, FDA, Tafinlar, Mekinist, trametinib, dabrafenib, metastatic melanoma
Eli Lilly And Merck: A Pipeline Of Success?
Seeking Alpha
Monday, September 16, 2013 - 5:26pm
tags:
Eli Lilly, Merck, Forest Labs
3 Things You Need to Know About This Big Pharma Deal
Motley Fool
Monday, September 16, 2013 - 5:25pm
tags:
Merck, AstraZeneca, MK-1775, MK-3475
FDA approves Teva's generic version of Roche cancer drug Xeloda
Reuters
Monday, September 16, 2013 - 3:46pm
tags:
generics, Teva, FDA, Roche, Xeloda, breast cancer, colorectal cancer
Italy's Chiesi to buy rest of Cornerstone Therapeutics
Reuters
Monday, September 16, 2013 - 3:45pm
tags:
Italy, M&A, Cornerstone Therapeutics, Chiesi
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Monday, September 16, 2013 - 11:48am
tags:
Celgene, FDA, Bristol-Myers Squibb, AbbVie, JNJ, Eli Lilly, Revlimid, Abraxane
Delcath dives again on final FDA denial of liver cancer treatment
Mass Device
Monday, September 16, 2013 - 11:19am
tags:
Delcath, FDA, liver cancer, devices, Melblez
Lufthansa CEO Franz Quits in Surprise Move to Roche
Bloomberg
Monday, September 16, 2013 - 11:13am
tags:
Roche, Pharma CEOs, Christoph Franz
Party drug ketamine gains steam for antidepressant use
Fierce Biotech
Monday, September 16, 2013 - 11:10am
tags:
JNJ, ketamine, antidepressants
FDA lifts hold on Pluristem's stem cell trial after tweaking protocol
Fierce Biotech
Monday, September 16, 2013 - 11:07am
tags:
FDA, Pluristem, stem cells, PLX-PAD, intermittent claudication
New Ranbaxy import ban provides Novartis with unexpected benefit
Fierce Pharma
Monday, September 16, 2013 - 11:06am
tags:
Ranbaxy, Novartis, Diovan, generics
Have These 4 Biotechs Peaked?
Motley Fool
Monday, September 16, 2013 - 11:04am
tags:
biotech, Alexion, Pharmacyclics, Aegerion, Raptor Pharmaceuticals
Epizyme: The Promise Of Personalized Cancer Therapy
Seeking Alpha
Monday, September 16, 2013 - 11:03am
tags:
Epizyme, personalized medicine, GSK, cancer, Eisai, epigenetics, Celgene
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
Yahoo
Monday, September 16, 2013 - 11:01am
tags:
FDA, orphan drugs, SGX94, Soligenix, acute radiation syndrome
OncoSec Medical Announces $12 Million Public Offering
Yahoo
Monday, September 16, 2013 - 10:57am
tags:
stock offering, OncoSec
Dendreon's Provenge: A Major Focus At The European Cancer Congress 2013
Seeking Alpha
Monday, September 16, 2013 - 10:56am
tags:
Dendreon, Provenge, Europe, prostate cancer
Advertising Starts On Arena's Belviq
Seeking Alpha
Monday, September 16, 2013 - 10:15am
tags:
drug ads, Arena Pharmaceuticals, Belviq, obesity, Eisai
Breakthrough status for GSK and Genmab leukemia drug
Pharma Times, UK
Monday, September 16, 2013 - 10:14am
tags:
GSK, Genmab, breakthrough therapies, Arzerra, chronic lymphocytic leukemia, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.